Advertisement
Table 1 Demographic and clinical characteristics of SLE patients
| Characteristic | SLE patients (n = 43) |
|---|---|
| Age (years; mean [range]) | 35.0 (21 to 56) |
| Sex (n; males/females) | 2/41 |
| Disease duration (years; mean [range]) | 8.5 (0.1 to 18) |
| SLEDAI (mean ± SD) | 3.72 ± 3.84 |
| Active (n = 9)a | 9.55 ± 4.50 |
| Inactive (n = 34) | 2.17 ± 1.42 |
| Cutaneous manifestation (n [%]) | 26 (60.5) |
| Arthritis (n [%]) | 27 (62.8) |
| Renal manifestation (n [%]) | 9 (20.9) |
| Cytopenia (n [%]) | 11 (25.6) |
| Serositis (n [%]) | 8 (18.6) |
| Prednisolone (n [%]; mean dosage [mg/day]) | 41 (95.3); 13.0 |
| Hydroxychloroquine (n [%]) | 34 (79.1) |
| Azathioprine (n [%]) | 4 (9.3) |
| Cyclosporin (n [%]) | 1 (2.3) |
| Mizoribine (n [%]) | 4 (9.3) |
| Mycophenolate mofetil (n [%]) | 3 (7.0) |
